BEACHWOOD, OH, Trailhead Biosystems, a biotechnology company advancing human cell innovation, has added $20 million in new funding.
Trailhead Biosystems, a biotechnology company advancing human cell innovation, has added $20 million in new funding, expanding the financing announced in May 2025 to $40 million. The funding extension was led by MAK Capital, with participation from additional investors.
(c) by Massinvestor, Inc. For contact info, please check out our
about page.
